Newsroom

News
06 June 2017

Congratulations to GHIT Fund on securing over US$200 Million to its replenishment

The Global Health Innovative Technology Fund (GHIT Fund), which financially supports the Pediatric Praziquantel Consortium, announced last week that it has...

Read more
Events
13 April 2017

Pediatric Praziquantel Consortium at the NTD Summit

2017 marks the 5th anniversary of the World Health Organization's (WHO) roadmap on Neglected Tropical Diseases (NTDs) and the London Declaration. To...

Read more
News
10 April 2017

Pediatric Praziquantel Consortium awarded US$4.7 million GHIT grant

On 30 Mar 2017, the GHIT Fund announced that it will continue to support the Pediatric Praziquantel Consortium. 

Read more
Events
20 March 2017

Consortium presenting at the ‘Towards Elimination of Schistosomiasis’ (TES) Conference in Cameroon

The Pediatric Praziquantel Consortium will be represented at the TES Conference that will be held on March 22-23, 2017 in Yaoundé (Cameroon).

Read more
News
16 March 2017

PLOS NTD highlights crucial role for expert meetings in NTD product development programs

Pediatric Praziquantel Consortium shares its experience with organizing expert meetings

Read more
Events
14 February 2017

‘Schistosomiasis’ featured at the ISNTD Festival

The Pediatric Praziquantel Consortium partners continue to engage with scientific and social communities in the fight against schistosomiasis. This...

Read more
News
14 November 2016

Attention for PEDPZQ Consortium in German newspapers

On October 19, Merck KGaA, Darmstadt, Germany announced the donation to the World Health Organization (WHO) of the 500 millionth tablets to treat...

Read more
News
02 November 2016

From the Program Lead: Team effort makes the difference

Reviewing the different accomplishments in the last half year fulfils me with a true sense of pride for our team. It is the combined effort from all the...

Read more
News
01 November 2016

Schistosomiasis in Côte d’Ivoire: An interview with Prof. Dr. Eliézer K. N’GORAN

The Pediatric Praziquantel Consortium has initiated the Phase II clinical trial in Côte d’Ivoire, in Schistosoma mansoni-infected preschool-age...

Read more

Pages